International Journal of Life science and Pharma Reviews (IJLPR)  
International Journal of Life science and Pharma Research (IJLPR)
Pharmaceutical Sciences
Volume 11 Issue 2, March 2021    Pages:58-67
Putative Role of Chloroquine In Amelioration of DSS Induced Ulcerative Colitis in Mice

AvikDas ,Srikanta Chandra, Lucky Mukherjee, Tathagata Roy and Preeta Bose
[View PDF]
Ulcerative colitis (UC) is a chronic ulceroinflammatory condition primarily confined with in colonic mucosa with variable distortion of the colonic architecture. It is associated with microbial overgrowth such as E.coli , S. typhi .However Chloroquine acts on these  microbes . In our present study the anticolitic effects of Chloroquine in treatment with the DSS induced model for UC in mice were examined. Male mice of age  7 weeks are chosen .They are assigned into different groups .Negative control groups treated with normal saline solution ,positive control group treated with DSS5%, standard group treated with Balsalazide 4mg/kg & DSS 5% , Test(1) group treated with Chloroquine 6mg/kg, Test(2) group treated with Chloroquine 8mg/kg, Test(3) group treated with Chloroquine 10 mg/kg then we performed  different parameters such as DAI, Oxidative damage assessment, MPO Assessment  and Histopathological evaluation. The results have showed that Chloroquine has significant activity against DSS(5%) induced colitis when compared to the experimental control, with near normalization of colon architecture. Tissue oxidative stress was reduced with significant improvement in tissue levels of MDA, GSH, SOD and CAT .Furthermore,significant improvement in levels of myeloperoxidase (MPO) was observed. It is concluded that Chloroquine(10mg/kg) has got potent activity against DSS(5%) induced ulcerative colitis(UC) due to its  anti inflammatory antioxidant properties.
Keywords: Ulcerative colitis, Anti inflammatory, Antioxidant, Chloroquine, Myeloperoxidase
© 2010-2015 IJLPR. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions